Flagship Harbor Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-189
Closed -$1.32K 2029
2025
Q4
$1.32K Buy
+189
New +$1.48K ﹤0.01% 1899
2021
Q4
Sell
-4,802
Closed -$799K 703
2021
Q3
$799K Hold
4,802
0.09% 253
2021
Q2
$799K Sell
4,802
-310
-6% -$50.2K 0.09% 254
2021
Q1
$929K Buy
5,112
+2,002
+64% +$464K 0.11% 206
2020
Q4
$622K Buy
3,110
+358
+13% +$72.8K 0.08% 264
2020
Q3
$603K Buy
2,752
+387
+16% +$82K 0.08% 228
2020
Q2
$451K Buy
2,365
+1,456
+160% +$255K 0.07% 273
2020
Q1
$141K Buy
909
+593
+188% +$69K 0.03% 460
2019
Q4
$26K Hold
316
﹤0.01% 1033
2019
Q3
$21K Sell
316
-300
-49% -$19.7K ﹤0.01% 1079
2019
Q2
$40K Hold
616
0.01% 829
2019
Q1
$34K Buy
616
+288
+88% +$17.6K 0.01% 879
2018
Q4
$16K Hold
328
﹤0.01% 1102
2018
Q3
$27K Hold
328
0.01% 1020
2018
Q2
$19K Buy
+328
New +$16K ﹤0.01% 1130

Other funds holding TDOC

Flagship Harbor Advisors's TDOC Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 189 shares — an estimated $1.32K sold.

Flagship Harbor Advisors first reported a position in TDOC in Q2 2018 and held it in 15 quarters. The position peaked at $929K in Q1 2021. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 189 Teladoc Health shares in Q1 2026, an estimated $1.32K.
  • Flagship Harbor Advisors first reported a position in Teladoc Health in Q2 2018 and held it in 15 quarters.
  • Flagship Harbor Advisors's Teladoc Health position peaked at $929K in Q1 2021.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.